Abstract
Use of second-generation antipsychotics (SGA) has increased in recent years; however, their use and effect on metabolic outcomes has been poorly characterised in population-level studies.AimsThis study aimed to determine the associations between SGA use and metabolic indicators in a general population. We used data from the Canadian Health Measures Survey, a cross-sectional survey of Canadian households. Participants were Canadians aged 3-79 years, living in one of the ten provinces. Several metabolic indicators were examined, including weight, body mass index, waist circumference, hypertension, diabetes and two definitions of metabolic syndrome. The proportion of Canadians taking an SGA tripled over the study period. SGA use was significantly associated with hypertension (odds ratio 1.94, 95% CI 1.07-3.55) and abdominal obesity in adults, as defined by the National Cholesterol Education Program-Adult Treatment Panel III (odds ratio 2.62, 95% CI 1.45-4.71). Evidence of metabolic dysfunction with SGAs is seen in the Canadian population, along with a rapid increase in prevalence of use since 2007.Declaration of interestNone.
References
Aug 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·P B Mortensen, K Juel
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·S Brown
Dec 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·E C Harris, B Barraclough
Oct 17, 2002·Clinical Therapeutics·Carolyn S DewaPaula Goering
Feb 6, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Jayme L OpolkaP J Gibson
Jun 4, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Diane M HerbeckLonnie R Snowden
Sep 3, 2005·Schizophrenia Research·Joseph P McEvoyJeffrey A Lieberman
Jan 20, 2006·International Clinical Psychopharmacology·Staffan HäggRolf Adolfsson
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Ayal SchafferAnthony Levitt
May 10, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·K G M M AlbertiJ Shaw
May 3, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Silvia Alessi-SeveriniMurray W Enns
Aug 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Anne Connolly, David Taylor
Jan 17, 2009·The American Journal of Psychiatry·Dan W HauptJohn W Newcomer
Nov 10, 2009·The Canadian Journal of Cardiology·A McFarlaneUNKNOWN Canadian Heart Health Strategy and Action Plan Theme Working Group 1
Jan 6, 2010·Archives of General Psychiatry·Elaine H MorratoJohn W Newcomer
Dec 6, 2011·Journal of Child and Adolescent Psychopharmacology·Tamara PringsheimScott B Patten
Jan 18, 2012·Current Opinion in Psychiatry·Thomas M LaursenMogens Vestergaard
Feb 3, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Silvia Alessi-SeveriniMurray W Enns
Jul 31, 2013·BMC Psychiatry·Andrea L MurphyStan P Kutcher
Jul 6, 2014·BioMed Research International·Nevena DivacNatasa Cerovac
Dec 9, 2014·CMAJ Open·Tamara Pringsheim, David M Gardner
Apr 18, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Scott B PattenJianLi Wang
Apr 18, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Keltie C McdonaldScott B Patten
Mar 24, 2016·BMJ Open·Diane DuncanTamara Pringsheim
Citations
Oct 18, 2018·Bipolar Disorders·Philip BoyceRichard J Porter
Oct 18, 2018·Bipolar Disorders·Roger MulderGin S Malhi
Feb 4, 2019·CNS Drugs·Gin S MalhiLauren Irwin
Nov 28, 2020·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sarra JaziDrigissa Ilies
Jul 9, 2021·Neuropsychiatric Disease and Treatment·Renato de FilippisPasquale De Fazio